Eli Lilly cuts cost of certain Zepbound doses by at least 50%
GuideStone Funds President Brandon Pizzurro says the company has ‘great prospects’ on ‘The Claman Countdown.’ Eli Lilly is expanding the supply of its weight-loss drug and selling it for half the price of other drugs in the highly lucrative market. […]
Eli Lilly cuts cost of certain Zepbound doses by at least 50% Read More »